文献速递临床微生物分子诊断

三种胶体金免疫法与GeneXpert Carba-R检测肺炎克雷伯菌blaKPC-2变异体的比较

Comparison of three colloidal gold immunoassays and GeneXpert Carba-R for the detection of Klebsiella pneumoniae blaKPC-2 variants.
PubMed 文献 · J Clin Microbiol · 2024-05-29

本研究用三种胶体金免疫试验和GeneXpert Carba-R检测42株肺炎克雷伯菌中的KPC-2碳青霉烯酶及其变异体。对KPC-2菌株,四种方法均与测序结果100%一致;对16种KPC-2变异体,GeneXpert Carba-R的PPA和NPA均为100%,三种胶体金试验NPA均为100%,但PPA分别为87.5%、87.5%和68.8%。

要点

  • GeneXpert Carba-R检测KPC-2及其变异体的PPA和NPA均为100%。
  • 三种胶体金试验对KPC-2变异体的PPA为87.5%、87.5%和68.8%。
  • 胶体金试验假阴性与其氨基酸突变位点相关,不符表型时建议复测。

核心结论

  • GeneXpert Carba-R是检测KPC-2及其变异体的可靠方法,胶体金免疫试验提供实用且成本效益好的检测途径。

研究设计与样本

  • 研究纳入42株肺炎克雷伯菌,涵盖blaKPC-2(13/42)及16种blaKPC-2变异体,比较三种胶体金免疫试验与GeneXpert Carba-R的检测性能。

主要发现

  • 对KPC-2菌株,四种方法均与测序结果100% NPA和100% PPA一致。
  • 对16种KPC-2变异体,GeneXpert Carba-R的NPA和PPA均为100%。
  • 三种胶体金试验对KPC-2变异体的NPA均为100%,Gold Mountainriver CGI、Dynamiker CGI和NG-Test CARBA5的PPA分别为87.5%、87.5%和68.8%。
  • 胶体金免疫试验假阴性结果与变异体氨基酸突变位点相关。

关键数值与推荐

  • 对KPC-2菌株,四种方法PPA和NPA均为100%。
  • 对KPC-2变异体,GeneXpert Carba-R的PPA和NPA均为100%;胶体金试验NPA均为100%,PPA分别为87.5%、87.5%和68.8%。
  • 胶体金试验阴性但不符合耐药表型时,建议改用另一种试剂盒或GeneXpert Carba-R复测。

临床怎么用

  • 检测KPC-2及其变异体时,GeneXpert Carba-R准确性高,可作为可靠方法。
  • 胶体金免疫试验可作为实用且成本较低的检测选择,但需注意对变异体的假阴性。
  • 胶体金试验阴性且与耐药表型不符时,应换用另一种试剂盒或GeneXpert Carba-R复测以提高准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The increasing use of ceftazidime-avibactam has led to the emergence of a wide range of ceftazidime-avibactam-resistant blaKPC-2 variants. Particularly, the conventional carbapenemase phenotypic assay exhibited a high false-negative rate for KPC-2 variants. In this study, three colloidal gold immunoassays, including the Gold Mountainriver CGI test, Dynamiker CGI test and NG-Test CARBA5, and GeneXpert Carba-R, were used to detect the presence of KPC-2 carbapenemase and its various variants in 42 Klebsiella pneumoniae strains. These strains covered blaKPC-2 (13/42) and 16 other blaKPC-2 variants including blaKPC-12 (1/42), blaKPC-23 (1/42), blaKPC-25 (1/42), blaKPC-33 (6/42), blaKPC-35 (1/42), blaKPC-44 (1/42), blaKPC-71 (1/42), blaKPC-76 (8/42), blaKPC-78 (1/42), blaKPC-79 (1/42), blaKPC-100 (1/42), blaKPC-127 (1/42), blaKPC-128 (1/42), blaKPC-144 (1/42), blaKPC-157 (2/42), and blaKPC-180 (1/42). For KPC-2 strains, all four assays showed 100% negative percentage agreement (NPA) and 100% positive percentage agreement (PPA) with sequencing results. For all 16 KPC-2 variants, GeneXpert Carba-R showed 100% NPA and 100% PPA, and the three colloidal gold immunoassays showed 100% NPA, while the PPAs of the Gold Mountainriver CGI test, Dynamiker CGI test, and NG-Test CARBA5 were 87.5%, 87.5%, and 68.8%, respectively. We also found a correlation between the mutation site in the amino acid of the variants and false-negative results by colloidal gold immunoassays. In conclusion, the GeneXpert Carba-R has been proven to be a reliable method in detecting KPC-2 and its variants, and the colloidal gold immunoassay tests offer a practical and cost-effective approach for their detection. For the sample with a negative result by a colloidal gold immunoassay test but not matching the drug-resistant phenotype, it is recommended to retest using another type of kit or the GeneXpert Carba-R assay, which can significantly improve the accuracy of detection.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Zhang J, Xu J, Shen S, et al. Comparison of three colloidal gold immunoassays and GeneXpert Carba-R for the detection of Klebsiella pneumoniae blaKPC-2 variants. J Clin Microbiol. 2024. PMID: 38809033. doi:10.1128/jcm.00154-24

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。